Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial

BACKGROUND: The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive inflammatory characteristics predict the benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Snoeck-Stroband, Jiska B., Lapperre, Therese S., Sterk, Peter J., Hiemstra, Pieter S., Thiadens, Henk A., Boezen, H. Marike, ten Hacken, Nick H. T., Kerstjens, Huib A. M., Postma, Dirkje S., Timens, Wim, Sont, Jacob K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699453/
https://www.ncbi.nlm.nih.gov/pubmed/26659582
http://dx.doi.org/10.1371/journal.pone.0143793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699453/
https://www.ncbi.nlm.nih.gov/pubmed/26659582
http://dx.doi.org/10.1371/journal.pone.0143793

Ejemplares similares